Skip to main content

Delivering anti-cancer drugs beyond the blood-brain barrier


Clinical Trial Authorization

Public document showing authorization for Cathera's pivotal trial in the DOMEUS project.

Searching for OpenAIRE data...


Safety and Feasibility of Repeated and Transient Blood–Brain Barrier Disruption by Pulsed Ultrasound in Patients with Recurrent Glioblastoma

Author(s): Ahmed Idbaih, Michael Canney, Lisa Belin, Carole Desseaux, Alexandre Vignot, Guillaume Bouchoux, Nicolas Asquier, Bruno Law-Ye, Delphine Leclercq, Anne Bissery, Yann De Rycke, Clementine Trosch, Laurent Capelle, Marc Sanson, Khe Hoang-Xuan, Caroline Dehais, Caroline Houillier, Florence Laigle-Donadey, Bertrand Mathon, Arthur André, Cyril Lafon, Jean-Yves Chapelon, Jean-Yves Delattre, Alexandre Ca
Published in: Clinical Cancer Research, 25/13, 2019, Page(s) 3793-3801, ISSN 1078-0432
Publisher: American Association for Cancer Research
DOI: 10.1158/1078-0432.ccr-18-3643